193 related articles for article (PubMed ID: 22328974)
21. A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression.
Vallot C; Stransky N; Bernard-Pierrot I; Hérault A; Zucman-Rossi J; Chapeaublanc E; Vordos D; Laplanche A; Benhamou S; Lebret T; Southgate J; Allory Y; Radvanyi F
J Natl Cancer Inst; 2011 Jan; 103(1):47-60. PubMed ID: 21173382
[TBL] [Abstract][Full Text] [Related]
22. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
[TBL] [Abstract][Full Text] [Related]
23. Oncogene mutation profiling reveals poor prognosis associated with FGFR1/3 mutation in liposarcoma.
Li C; Shen Y; Ren Y; Liu W; Li M; Liang W; Liu C; Li F
Hum Pathol; 2016 Sep; 55():143-50. PubMed ID: 27237367
[TBL] [Abstract][Full Text] [Related]
24. Selective elimination of amplified CDK4 sequences correlates with spontaneous adipocytic differentiation in liposarcoma.
Hélias-Rodzewicz Z; Pédeutour F; Coindre JM; Terrier P; Aurias A
Genes Chromosomes Cancer; 2009 Nov; 48(11):943-52. PubMed ID: 19626636
[TBL] [Abstract][Full Text] [Related]
25. Restoration of C/EBPα in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis.
Wu YV; Okada T; DeCarolis P; Socci N; O'Connor R; Geha RC; Joy Somberg C; Antonescu C; Singer S
Genes Chromosomes Cancer; 2012 Apr; 51(4):313-27. PubMed ID: 22170698
[TBL] [Abstract][Full Text] [Related]
26. Integrated exome and RNA sequencing of dedifferentiated liposarcoma.
Hirata M; Asano N; Katayama K; Yoshida A; Tsuda Y; Sekimizu M; Mitani S; Kobayashi E; Komiyama M; Fujimoto H; Goto T; Iwamoto Y; Naka N; Iwata S; Nishida Y; Hiruma T; Hiraga H; Kawano H; Motoi T; Oda Y; Matsubara D; Fujita M; Shibata T; Nakagawa H; Nakayama R; Kondo T; Imoto S; Miyano S; Kawai A; Yamaguchi R; Ichikawa H; Matsuda K
Nat Commun; 2019 Dec; 10(1):5683. PubMed ID: 31831742
[TBL] [Abstract][Full Text] [Related]
27. Clinical and Molecular Spectrum of Liposarcoma.
Lee ATJ; Thway K; Huang PH; Jones RL
J Clin Oncol; 2018 Jan; 36(2):151-159. PubMed ID: 29220294
[TBL] [Abstract][Full Text] [Related]
28. Spindle cell liposarcoma with a TRIO-TERT fusion transcript.
Suster DI; Deshpande V; Chebib I; Taylor MS; Mullen J; Bredella MA; Nielsen GP
Virchows Arch; 2019 Sep; 475(3):391-394. PubMed ID: 30793229
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression and DNA methylation profiles do not distinguish between primary and recurrent well-differentiated liposarcoma.
Vos M; Boers R; Vriends ALM; Boers J; van Kuijk PF; van Houdt WJ; van Leenders GJLH; Wagrodzki M; van IJcken WFJ; Gribnau J; Grünhagen DJ; Verhoef C; Sleijfer S; Wiemer EAC
PLoS One; 2020; 15(1):e0228014. PubMed ID: 31971976
[TBL] [Abstract][Full Text] [Related]
30. Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
Mazzu YZ; Yoshikawa Y; Nandakumar S; Chakraborty G; Armenia J; Jehane LE; Lee GM; Kantoff PW
Mol Oncol; 2019 Sep; 13(9):1944-1958. PubMed ID: 31225930
[TBL] [Abstract][Full Text] [Related]
31. MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors.
Ware PL; Snow AN; Gvalani M; Pettenati MJ; Qasem SA
Am J Clin Pathol; 2014 Mar; 141(3):334-41. PubMed ID: 24515760
[TBL] [Abstract][Full Text] [Related]
32. Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma.
Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Pérez-Mancera PA; Pintado B; Flores T; Battaner E; Sánchez-Garćia I
Oncogene; 2000 Dec; 19(52):6015-22. PubMed ID: 11146553
[TBL] [Abstract][Full Text] [Related]
33. Involvement of epigenetics and microRNA-29b in the urethane induced inception and establishment of mouse lung tumors.
Pandey M; Sultana S; Gupta KP
Exp Mol Pathol; 2014 Feb; 96(1):61-70. PubMed ID: 24361357
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
[TBL] [Abstract][Full Text] [Related]
35. c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.
Snyder EL; Sandstrom DJ; Law K; Fiore C; Sicinska E; Brito J; Bailey D; Fletcher JA; Loda M; Rodig SJ; Dal Cin P; Fletcher CD
J Pathol; 2009 Jul; 218(3):292-300. PubMed ID: 19449367
[TBL] [Abstract][Full Text] [Related]
36. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
[TBL] [Abstract][Full Text] [Related]
37. Adipogenesis induces growth inhibition of dedifferentiated liposarcoma.
Kim YJ; Yu DB; Kim M; Choi YL
Cancer Sci; 2019 Aug; 110(8):2676-2683. PubMed ID: 31069877
[TBL] [Abstract][Full Text] [Related]
38. Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe.
Willmore-Payne C; Holden J; Turner KC; Proia A; Layfield LJ
Arch Pathol Lab Med; 2008 Jun; 132(6):952-7. PubMed ID: 18517278
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3.
Kang KA; Zhang R; Kim GY; Bae SC; Hyun JW
Tumour Biol; 2012 Apr; 33(2):403-12. PubMed ID: 22274925
[TBL] [Abstract][Full Text] [Related]
40. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
